Notification Letter to Registered Shareholders and Change Request Form - 2026 Interim Report
Filed with HKEX · Stock code 1498 · · 2 pages · English and Chinese
The Current Corporate Communications of the Company has been published in English and Chinese languages and are available on the website of The Stock Exchange of Hong Kong Limited (“HKEX”) at www.hkexnews.hk and the Company’s website at www.purapharm.com. If you have any difficulty in receiving or gaining access to the Current Corporate Communications posted on the Company’s website for any reason
Earlier from PuraPharm
- Interim Report 2026
- Proposed change of auditor
- Resignation of chief financial officer, change of company secretary and authorised representative
- (I) proposed re-election of retiring directors; (II) proposed grant of general mandates to buy back shares and issue new shares; (iii) proposed refreshment of Scheme Mandate Limit under the share option scheme; (IV) proposed change of company name; (v) proposed amendments to the Articles of Association of the company; and notice of annual general meeting
- Extension of long stop date for connected transaction
Later from PuraPharm
- Notification Letter to Non-registered Shareholders and Request Form - 2026 Interim Report
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
- Proposed change of auditor and notice of extraordinary general meeting
- Notice of extraordinary general meeting
- Proxy form for extraordinary general meeting
Follow PuraPharm into a list and get an email when it puts out news.
Follow PuraPharm